Y-H Im

Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease

Hahm Kb, Y-H Im, W. Tony Parks et al. · Gut · 2001 · 193 citations · Full text

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

Hope S. Rugo, Joyce O’Shaughnessy, F Boyle et al. · Annals of Oncology · 2022 · 109 citations · Full text

Abstract S3-2: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Antitumor and Safety Analysis of a Randomized Phase II Study ('NeoSphere')

Luca Gianni, Tadeusz Pieńkowski, Y-H Im et al. · Cancer Research · 2010 · 67 citations

Breast Oncology, Cancer Management, Pathology +16

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

S T Kim, Wonseok Kang, Joon Ho Kang et al. · British Journal of Cancer · 2005 · 62 citations · Full text

S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).

Luca Gianni, Giampaolo Bianchini, Astrid Kiermaier et al. · Cancer Research · 2011 · 49 citations

Biomarker Analyses, Breast Oncology, Immunology +22